{"name":"Shanghai Acebright Pharmaceuticals Co., Ltd.","slug":"shanghai-acebright-pharmaceuticals-co-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Simmiparib","genericName":"Simmiparib","slug":"simmiparib","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"Simmiparib","genericName":"Simmiparib","slug":"simmiparib","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiYkFVX3lxTFBXV2k1UU5UVFh0bkozVmJpUnRCNjNWMDBqM0x5dW02OC12d1ZxT2dqX1Vpc1VWZXRaZTMwMnBxR2poV0R4UVNmX2ZwM205UTFFdzZoblBiQXc2ODhkVWNGc1Rn?oc=5","date":"2023-03-16","type":"pipeline","source":"Straits Research","summary":"Riboflavin Market Size, Share & Trends | Industry Report, 2033 - Straits Research","headline":"Riboflavin Market Size, Share & Trends | Industry Report, 2033","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirwFBVV95cUxNek1CWkRjWVZIRzgwQ3cwZlJpb3N6V3BDYVRMM3FfUmRScXFDZXVDN1dQTS04ZV9FQkhSb194d25SLUhiOHJvQ2ItV0E2R1NiQmhPOUJRelQ1R3VqWl90d3g3U0RtUzI3SnNDTzM4Q0lTbFp3aG9iWUhMdjlOUGpYbm5sTEdqaFBHUFY4cmNQdDYxeFU5Z0xaNlkwMUdNMFJCMWY3MUM5SGZFOEtsMEFV?oc=5","date":"2019-07-17","type":"pipeline","source":"Fierce Pharma","summary":"Top Indian drugmakers expand in China as policy changes trigger opportunity - Fierce Pharma","headline":"Top Indian drugmakers expand in China as policy changes trigger opportunity","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2019-07-16","type":"pipeline","source":"Moneycontrol.com","summary":"Cipla inks pact with Acebright Group to build respiratory biz in China - Moneycontrol.com","headline":"Cipla inks pact with Acebright Group to build respiratory biz in China","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_1":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}